JP2011522553A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2011522553A5 JP2011522553A5 JP2011512983A JP2011512983A JP2011522553A5 JP 2011522553 A5 JP2011522553 A5 JP 2011522553A5 JP 2011512983 A JP2011512983 A JP 2011512983A JP 2011512983 A JP2011512983 A JP 2011512983A JP 2011522553 A5 JP2011522553 A5 JP 2011522553A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- composition according
- growth factor
- interleukin
- range
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000008194 pharmaceutical composition Substances 0.000 claims 10
- 102000003745 Hepatocyte Growth Factor Human genes 0.000 claims 6
- 108090000100 Hepatocyte Growth Factor Proteins 0.000 claims 6
- 102000004889 Interleukin-6 Human genes 0.000 claims 6
- 108090001005 Interleukin-6 Proteins 0.000 claims 6
- 102000004890 Interleukin-8 Human genes 0.000 claims 6
- 108090001007 Interleukin-8 Proteins 0.000 claims 6
- 229940100601 interleukin-6 Drugs 0.000 claims 6
- 229940096397 interleukin-8 Drugs 0.000 claims 6
- XKTZWUACRZHVAN-VADRZIEHSA-N interleukin-8 Chemical compound C([C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@@H](NC(C)=O)CCSC)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N[C@@H](CCSC)C(=O)N1[C@H](CCC1)C(=O)N1[C@H](CCC1)C(=O)N[C@@H](C)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CCC(O)=O)C(=O)N[C@H](CC(O)=O)C(=O)N[C@H](CC=1C=CC(O)=CC=1)C(=O)N[C@H](CO)C(=O)N1[C@H](CCC1)C(N)=O)C1=CC=CC=C1 XKTZWUACRZHVAN-VADRZIEHSA-N 0.000 claims 6
- 108010073929 Vascular Endothelial Growth Factor A Proteins 0.000 claims 4
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 claims 4
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 claims 4
- 210000004027 cell Anatomy 0.000 claims 4
- 238000012258 culturing Methods 0.000 claims 4
- 102000049853 macrophage stimulating protein Human genes 0.000 claims 4
- 108010053292 macrophage stimulating protein Proteins 0.000 claims 4
- 239000003636 conditioned culture medium Substances 0.000 claims 3
- 239000001963 growth medium Substances 0.000 claims 3
- 210000003494 hepatocyte Anatomy 0.000 claims 3
- 210000004185 liver Anatomy 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 239000000203 mixture Substances 0.000 claims 3
- 102000003974 Fibroblast growth factor 2 Human genes 0.000 claims 2
- 108090000379 Fibroblast growth factor 2 Proteins 0.000 claims 2
- 101500025419 Homo sapiens Epidermal growth factor Proteins 0.000 claims 2
- 239000006143 cell culture medium Substances 0.000 claims 2
- 210000003237 epithelioid cell Anatomy 0.000 claims 2
- 229940116978 human epidermal growth factor Drugs 0.000 claims 2
- GVUGOAYIVIDWIO-UFWWTJHBSA-N nepidermin Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O)NC(=O)CNC(=O)[C@@H](NC(=O)[C@@H](NC(=O)[C@H](CS)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CS)NC(=O)[C@H](C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCSC)NC(=O)[C@H](CS)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CS)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC=1NC=NC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CS)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O)C(C)C)[C@@H](C)CC)C(C)C)C(C)C)C1=CC=C(O)C=C1 GVUGOAYIVIDWIO-UFWWTJHBSA-N 0.000 claims 2
- 210000002966 serum Anatomy 0.000 claims 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 1
- 102000008100 Human Serum Albumin Human genes 0.000 claims 1
- 108091006905 Human Serum Albumin Proteins 0.000 claims 1
- 206010053159 Organ failure Diseases 0.000 claims 1
- 150000001413 amino acids Chemical class 0.000 claims 1
- 239000002577 cryoprotective agent Substances 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 239000008103 glucose Substances 0.000 claims 1
- 210000003734 kidney Anatomy 0.000 claims 1
- 210000004962 mammalian cell Anatomy 0.000 claims 1
- 210000000056 organ Anatomy 0.000 claims 1
- 230000008816 organ damage Effects 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 210000000130 stem cell Anatomy 0.000 claims 1
- 238000010257 thawing Methods 0.000 claims 1
- 239000011782 vitamin Substances 0.000 claims 1
- 229940088594 vitamin Drugs 0.000 claims 1
- 229930003231 vitamin Natural products 0.000 claims 1
- 235000013343 vitamin Nutrition 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08010651 | 2008-06-11 | ||
| EP08010651.1 | 2008-06-11 | ||
| PCT/EP2009/057232 WO2009150199A1 (en) | 2008-06-11 | 2009-06-11 | Conditioned medium of liver progenitor cells |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2011522553A JP2011522553A (ja) | 2011-08-04 |
| JP2011522553A5 true JP2011522553A5 (https=) | 2012-07-12 |
| JP5632833B2 JP5632833B2 (ja) | 2014-11-26 |
Family
ID=40905279
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2011512983A Active JP5632833B2 (ja) | 2008-06-11 | 2009-06-11 | 肝臓前駆細胞の馴化培地 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US10456425B2 (https=) |
| EP (1) | EP2296672B1 (https=) |
| JP (1) | JP5632833B2 (https=) |
| CN (2) | CN102119031B (https=) |
| BR (1) | BRPI0909866B1 (https=) |
| CA (1) | CA2727392C (https=) |
| DK (1) | DK2296672T3 (https=) |
| ES (1) | ES2556630T3 (https=) |
| HU (1) | HUE028676T2 (https=) |
| PL (1) | PL2296672T3 (https=) |
| PT (1) | PT2296672E (https=) |
| WO (1) | WO2009150199A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2333047A1 (en) | 2009-12-09 | 2011-06-15 | Fresenius Medical Care Deutschland GmbH | Adult stem cell derived conditioned medium and/or adult stem cells for use in the therapeutic treatment of a tumor disease |
| US8603470B1 (en) * | 2012-08-07 | 2013-12-10 | National Cheng Kung University | Use of IL-20 antagonists for treating liver diseases |
| ES2759228T3 (es) | 2013-07-05 | 2020-05-08 | Univ Catholique Louvain | Medio acondicionado de células madre de hígado de adultos y su uso en el tratamiento de trastornos del hígado |
| US10385114B2 (en) | 2013-09-05 | 2019-08-20 | Inis Biotech Llc | SPARC (secreted protein, acidic and rich in cysteine), a new target for the treatment and prevention of acute liver failure |
| RU2644650C2 (ru) * | 2014-12-01 | 2018-02-13 | Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" | Материал стволовых клеток и способ его получения |
| CN104818245B (zh) * | 2015-05-29 | 2020-02-04 | 广州赛莱拉干细胞科技股份有限公司 | 一种肝脏干细胞的培养基及培养方法 |
| WO2017139455A1 (en) | 2016-02-10 | 2017-08-17 | Wake Forest University Health Sciences | Model system of liver fibrosis and method of making and using the same |
| RU2708329C2 (ru) | 2016-05-31 | 2019-12-05 | Общество с ограниченной ответственностью "Т-Хелпер Клеточные Технологии" | Материал стволовых клеток, композиции и способы применения |
| WO2018119142A1 (en) | 2016-12-21 | 2018-06-28 | Amgen Inc. | Anti-tnf alpha antibody formulations |
| JP2021526556A (ja) | 2018-05-30 | 2021-10-07 | ダイレクト バイオロジクス エルエルシー | 成長因子および細胞外小胞を凍結または粉状にした、間葉系幹細胞(msc)の調製物を含む助剤、ならびにその使用方法 |
| CN109628377A (zh) * | 2019-01-02 | 2019-04-16 | 贵州省人民医院 | 一种小鼠原代肝细胞灌注式分离及离体培养方法 |
| CN111607556B (zh) | 2019-01-25 | 2022-06-07 | 中国科学院广州生物医药与健康研究院 | 一种培养扩增人肝祖细胞的培养基及其应用 |
| BR112021015549A2 (pt) | 2019-02-07 | 2021-10-26 | Direct Biologics Llc | Método para tratar osteoartrite com uma combinação de exossomos de células tronco mesenquimais, células tronco mesenquimais sinoviais e andaimes |
| DK3963050T3 (da) * | 2019-04-30 | 2023-12-11 | Cellaion Sa | Forberedelse af humane allogene leverderiverede progenitorceller |
| CN111394391B (zh) * | 2019-07-11 | 2022-12-06 | 上海赛立维生物科技有限公司 | 肝祖细胞样细胞库的构建方法及其制备的细胞株与应用 |
| CA3146433A1 (en) | 2019-07-18 | 2021-01-21 | Direct Biologics Llc | Preparations comprising mesenchymal stem cells and cannabinoids and methods of their use |
| US12590310B2 (en) | 2020-04-22 | 2026-03-31 | Direct Biologics, Llc | Methods and compositions for treating inflammatory conditions associated with infectious disease |
| US12502407B2 (en) | 2024-04-25 | 2025-12-23 | Direct Biologics, Llc | Treatment of fistula with bone marrow mesenchymal stem cell derived extracellular vesicles |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH093099A (ja) * | 1995-06-20 | 1997-01-07 | Toyobo Co Ltd | マクロファージ刺激蛋白質改変体およびその製造法 |
| US6475490B1 (en) * | 1998-10-19 | 2002-11-05 | Fordham University | Compositions and methods for promoting tissue repair using heat shock proteins |
| US6372494B1 (en) * | 1999-05-14 | 2002-04-16 | Advanced Tissue Sciences, Inc. | Methods of making conditioned cell culture medium compositions |
| US6719969B1 (en) * | 1999-08-09 | 2004-04-13 | The Regents Of The University Of Michigan | Treatment of liver disease and injury with CXC chemokines |
| CA2290240C (en) * | 1999-11-24 | 2008-03-11 | Stergios Stergiopoulos | High resolution 3d ultrasound imaging system deploying a multi-dimensional array of sensors and method for multi-dimensional beamforming sensor signals |
| US7547674B2 (en) * | 2001-06-06 | 2009-06-16 | New York Medical College | Methods and compositions for the repair and/or regeneration of damaged myocardium |
| US6916770B2 (en) | 2001-04-27 | 2005-07-12 | Polyone Corporation | Multi-functional color concentrate compositions |
| EP1406573A4 (en) * | 2001-06-07 | 2005-03-30 | Skinmedica Inc | CONDITIONED CELL CULTURE MEDIA AND ITS USES |
| CA2463914A1 (en) * | 2001-10-18 | 2003-04-24 | Ixion Biotechnology, Inc. | Conversion of liver stem and progenitor cells to pancreatic functional cells |
| WO2006126219A1 (en) | 2005-05-26 | 2006-11-30 | Fresenius Medical Care Deutschland G.M.B.H. | Liver progenitor cells |
| CA2642664A1 (en) * | 2006-02-16 | 2007-08-30 | Burnham Institute For Medical Research | Media conditioned by human embryonic stem cells or other progenitor cells and uses therefor |
| EP2422802A3 (en) * | 2006-03-07 | 2013-03-06 | Geeta Shroff | Compositions comprising human embryonic stem cells and their derivatives, methods of use, and methods of preparation |
| FR2912916B1 (fr) * | 2007-02-26 | 2009-05-22 | Oreal | Composition cosmetique ou dermatologique comprenant un milieu de culture cellulaire |
-
2009
- 2009-06-11 BR BRPI0909866-6A patent/BRPI0909866B1/pt active IP Right Grant
- 2009-06-11 WO PCT/EP2009/057232 patent/WO2009150199A1/en not_active Ceased
- 2009-06-11 US US12/737,143 patent/US10456425B2/en active Active
- 2009-06-11 EP EP09761761.7A patent/EP2296672B1/en active Active
- 2009-06-11 DK DK09761761.7T patent/DK2296672T3/en active
- 2009-06-11 HU HUE09761761A patent/HUE028676T2/en unknown
- 2009-06-11 CN CN200980131229.6A patent/CN102119031B/zh active Active
- 2009-06-11 PL PL09761761T patent/PL2296672T3/pl unknown
- 2009-06-11 CN CN201310348088.1A patent/CN103800895B/zh active Active
- 2009-06-11 CA CA2727392A patent/CA2727392C/en active Active
- 2009-06-11 ES ES09761761.7T patent/ES2556630T3/es active Active
- 2009-06-11 JP JP2011512983A patent/JP5632833B2/ja active Active
- 2009-06-11 PT PT97617617T patent/PT2296672E/pt unknown
-
2017
- 2017-01-23 US US15/412,142 patent/US10357519B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2011522553A5 (https=) | ||
| US20210008106A1 (en) | Mitochondrial treatment of organs for transplantation | |
| AU2019355201B2 (en) | Methods for the expansion of mesenchymal stromal cells | |
| Johansson et al. | Mechanisms for absorption enhancement of inhaled insulin by sodium taurocholate | |
| CN102985130A (zh) | 移植来自实体组织的细胞的方法 | |
| CN110177872A (zh) | 间充质干细胞和药物组合物 | |
| JP2023537204A (ja) | 間葉系ストローマ細胞由来の細胞外小胞(ev)および前記evを得るための方法 | |
| CN107114356A (zh) | 一种胎盘及脐带细胞保护液 | |
| CN105377275A (zh) | 用于静脉给药的干细胞组合物 | |
| CA3134435A1 (en) | Adult liver progenitor cells for treating acute-on-chronic liver failure | |
| WO2023200882A1 (en) | Compositions and methods for treating post acute sequelae of sars-cov-2 infection (long covid) | |
| WO2021069553A1 (en) | Use of liver progenitor or stem cells, lysates thereof, and/or conditioned medium in disorders characterized by vascular hyperpermeability | |
| WO2020193715A1 (en) | Adult liver progenitor cells for treating non-alcoholic fatty liver disease | |
| WO2023077160A1 (en) | Methods of treating diseases associated with cellular-energy deficiency or mitochondrial dysfunction by locoregional delivery of extracellular vesicles that have a cargo with an enhanced bioenergetic profile | |
| CN101037667A (zh) | 一种动物细胞的超低温保存溶液及保存方法 | |
| WO2021181394A1 (en) | Methods and compositions for treating viral infections and sequelae thereof | |
| CN107980767B (zh) | 一种长期保存过表达ang-1的epc的保存液 | |
| Malmros et al. | Dynamic accumulation of neutrophils in lungs and visceral organs during early abdominal sepsis in the pig | |
| CN105532646A (zh) | 肝细胞保存液及其制备方法和应用 | |
| JP7523441B2 (ja) | Hla-eを発現する肝臓前駆細胞を含む細胞組成物 | |
| CN103301118A (zh) | 注射用精氨酸布洛芬组合物 | |
| CN115715221A (zh) | 用于治疗或预防多器官功能障碍综合征的组合物和方法 | |
| CN115627250B (zh) | 用于培养昆虫细胞的无血清培养基及其应用 | |
| CN103301117A (zh) | 注射用盐酸氨溴索组合物 | |
| US20260069745A1 (en) | Biologic composition for promoting wound healing and a method of preparing the same |